Clinical Trials on A mellékpajzsmirigy daganatai

Total 4798 results

CerbaXpert

Not yet recruiting

Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier (Pregiferon)

Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons
Consorci Sanitari de l'Alt Penedès i Garraf
Institut Català de la Salut

Recruiting

Open Label Randomized Clinical Trial to Assess the Safety of Teleconsultation (ECASeT)

Various Clinical Conditions Commonly Followed up in a Secondary Hospital

Spain
University of Alabama at Birmingham

Withdrawn

A Noninvasive Arterial Input Estimation Method for O-15 PET and Integrated PET/MR Scanning (O-15 Water)

Validation of a New Noninvasive Method to Obtain the Arterial Input Function (AIF) Directly by PET Imaging

United States
Assistance Publique - Hôpitaux de Paris

Completed

Population Pharmacokinetics of Antiretroviral in Children (POPARV)

Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed

France
University Hospital, Bordeaux
University of Bordeaux

Completed

Evaluation of the Health Digital Territories Program in the Five Pilot Territories (EvaTSN Project ) (EvaTSN)

Evaluation of a National Health Information Technology-based Program to Improve Healthcare Coordination and Access to Information

France
Université de Sherbrooke
Fonds de la Recherche en Santé du Québec; BSN Medical Inc

Completed

Effects of Right Lower Limb Orthopedic Immobilization on Braking Function

Automobile Driving With an Aircast Walker | Automobile Driving With a Walking Cast

Canada
Chang Gung Memorial Hospital

Not yet recruiting

Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath

Port-a-cath Occlusion | Normal Saline | Heparin Lock
Silence Therapeutics plc

Active, not recruiting

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

Cardiovascular Diseases | Atherosclerosis | Lipoprotein(a)

Australia, Czechia, Denmark, Netherlands, Slovakia, South Africa, United Kingdom
Assistance Publique Hopitaux De Marseille

Completed

Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans (PIG-A)

Patient With Breast Cancer

France
Eda Cetin Ozdemir

Completed

Volumetric Changes in Free Gingival Graft Procedures Taken With Different Techniques

Ndirectly Measuring the Difference Between the Free Gingival Graft and the Free Gingival Unit Via a Scanner

Turkey
University Hospital Plymouth NHS Trust

Terminated

Enteral Feeding in Discharged Patients

Surgical Resection of an Upper Gastrointestinal Malignancy | Nutritional Supplementation Via a Jejunostomy Post Discharge From Hospital

United Kingdom
Takeda

Recruiting

A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

Acquired Hemophilia A

Japan
N.N. Petrov National Medical Research Center of...

Recruiting

Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) (VAB)

Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB

Russian Federation
Novo Nordisk A/S

Completed

Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) (Pathfinder10)

Haemophilia A

China
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Acquired Hemophilia A

United States, Italy, United Kingdom, Germany, Austria, Netherlands, France
Baxalta now part of Shire

Completed

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

Acquired Hemophilia A

United States, Canada, India, United Kingdom
OPKO Health, Inc.

Completed

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Hemophilia A or B With Inhibitors

Israel
Peking Union Medical College Hospital

Unknown

Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A

Acquired Hemophilia A

China
Merck Sharp & Dohme LLC

Completed

Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)

Hepatitis A Virus
Georgetown University
Genentech, Inc.

Terminated

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Hemophilia A
Hospital Universitario La Paz

Unknown

Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors

Severe Haemophilia A With Inhibitors

Spain
Recoly N.V.

Completed

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

Haemophilia A

Russian Federation
Skane University Hospital

Completed

The FEIBA NovoSeven Comparative Study

Severe Hemophilia A With an Inhibitor

Sweden
Tri-Service General Hospital

Recruiting

A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

Severe Hemophilia A Without Inhibitor

Taiwan
Institute of Hematology & Blood Diseases Hospital

Recruiting

An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A (AHA2023)

Acquired Hemophilia

China
Groupe Maladies hémorragiques de Bretagne

Recruiting

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A (GIDEMHA)

Desmopressin | Hemophilia A, Mild | Factor VIII

France
University of Washington
Genentech, Inc.

Recruiting

Emicizumab in Patients With Acquired Hemophilia A (AHAEmi)

Acquired Hemophilia A

United States
Novo Nordisk A/S

Enrolling by invitation

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® (pathfinder9)

Haemophilia A

Austria, Spain, Bulgaria, Croatia, Estonia, Hungary, Italy, Lithuania, Portugal, Greece, Germany, Czechia, Slovenia, Switzerland, Slovakia
Chulalongkorn University

Completed

Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A

Severe Hemophilia A Without Inhibitor

Thailand
Baxalta now part of Shire

No longer available

Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies

Acquired Hemophilia A

United States
The Hospital for Sick Children
Unity Health Toronto; Nationwide Children's Hospital; Canadian Hemophilia Society

Unknown

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Mild Haemophilia A Without Inhibitor

Canada
Central Hospital, Nancy, France

Completed

Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry (FOGTEP)

Patients Over 75 Years Old With a Cancer Discovery

France
University Hospital, Brest
Bayer

Completed

Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban (ESPER)

Blood Loss After a Total Hip Replacement

France
National Taiwan University Hospital

Unknown

Using a Thermal Imaging System to Evaluate the Wound of Port-A and the Relationship Between Thermal Images and Infection

Wound Healing Disturbance of Port-A

Taiwan
Novo Nordisk A/S

Withdrawn

Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

Healthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B
Novo Nordisk A/S

Completed

A Research Study Investigating Mim8 in People With Haemophilia A (FRONTIER1)

Healthy Volunteers | Haemophilia A With or Without Inhibitors

United States, Germany, Spain, Austria, Bulgaria, Italy, Japan, South Africa, Switzerland, Turkey, United Kingdom, Poland
China Medical University Hospital

Unknown

Inherited Myokymia: A Clinical and Genetic Study of a Family

A Study of Clinical and Genetic Mutations in a Family of Neuromyotonia, so Called Isaac's Syndrome

Taiwan
Novo Nordisk A/S

Completed

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (HAEMOcare)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

India, Morocco, South Africa, Oman
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

Spain
MetaMedia Training International, Inc.

Completed

Evaluation of Virtual Reality in Hazmat Training

Evaluating a Brief Intervention | No Disease or Condition is Being Studied | Does Virtual Reality Aid in Hazmat Training

United States
Andalas University
Indonesia University

Completed

The Effect of Maternal Dadiah Supplementation During Pregnancy on Child Growth and Gastrointestinal Health Outcomes

Gastrointestinal Microbiome | Growth; Stunting, Nutritional | Immunoglobulin A

Indonesia
Eyegate Pharmaceuticals, Inc.

Completed

OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)

Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal

United States
Rambam Health Care Campus

Unknown

Soft and Hard Tissue Changes Around the New Lance® Implants Using Traditional and Switch Platform Abutments

Group A- 23 Implant Using Switch Platform -SPK Abutment. | Group B- 22 Implant Using the Traditional -CPK Abutment.

Israel
Michigan State University

Not yet recruiting

Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion (HPV videos)

N/A - Healthy Subjects
University Medical Center Groningen
Accare; Hanzehogeschool Groningen; GGZ Friesland; WIJ Groningen; Amaryllis Leeuwarden

Recruiting

KOPPeling: Help From Your Own Circle

Children of Parents With a Mental Illness (COPMI)

Netherlands
University of Padova
Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine... and other collaborators

Completed

How Anxiety in Pregnant Hospitalized Women Change wIth Internet Use (HAWAII)

Pregnant Women in All Gestational Ages Hospitalized for a Problem of Pregnancy
Institute of Liver and Biliary Sciences, India

Completed

Effectiveness of Mindfulness Based Meditation on Well-being, Self Compassion & Cognizance Among Nurses Working in Intensive Care Units

Mindfulness is a Moment by Moment Awareness to Remain Purposefully and Non Judgmentally Attentive to Their Own Experience

India
Stefan Gilg, MD, PhD

Unknown

Early Liver Support With MARS in Post-hepatectomy Liver Failure (ELISH)

Liver Failure as A Complication of Care
Everest Medicines (Singapore) Pte. Ltd.

Active, not recruiting

Efficacy and Safety in Chinese Patients With Immunoglobulin A Nephropathy (IgAN) Who Have Completed Study Nef-301

Primary Immunoglobulin A Nephropathy (IgAN)

China
Groupe Maladies hémorragiques de Bretagne

Completed

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A (GIDEHAC)

Factor VIII Deficiency | Desmopressin | Carrier of Hemophilia A

France

Clinical Trials on A mellékpajzsmirigy daganatai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations